NY State Senate Bill 2025-S56A

Current Bill Status - In Senate Committee Health Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Jan 13, 2025	print number 56a
Jan 13, 2025	amend and recommit to health
Jan 08, 2025	referred to health

Bill Amendments

Original

A (Active)

co-Sponsors

View additional co-sponsors

2025-S56 - Details

See Assembly Version of this Bill:: A808
Current Committee:: Senate Health
Law Section:: Public Health Law
Laws Affected:: Add §3309-c, Pub Health L

2025-S56 - Summary

Establishes through the department of health a drug checking program to allow individuals to bring drugs or controlled substances and have them tested for contaminants, toxic substances, or hazardous compounds; requires the department to establish public health surveillance of the unregulated drug supply.

2025-S56 - Sponsor Memo

                                 
BILL NUMBER: S56

SPONSOR: FERNANDEZ
 
TITLE OF BILL:

An act to amend the public health law, in relation to establishing a
drug checking program including requirements for enhanced drug checking
service delivery and public health surveillance

 
PURPOSE OR GENERAL IDEA OF BILL:

To create a drug checking services program to assist individuals in
determining whether a drug or controlled substance contains conta
minants, toxic substances, or hazardous compounds.

 
SUMMARY OF PROVISIONS:

Section 1 establishes the drug checking services program.

Section 2 sets the effective date.

JUSTIFICATION:

New York is in the middle of an overdose epidemic. For the past few
years, New York has exceeded national rates of opioid overdose deaths
with over 30 individuals per 100,000 dying from drug overdoses.  The
amount of opioid deaths grew almost 300% between 2010 and 20 20, effec-
tively responsible for 85% of all drug overdose deaths in New York in
2020.

In 2017 the CDC published a findings report of the state-level economic
costs of opioid use disorder and fatal opioid overdoses.  It found
opioid use disorder has cost New York State an estimated $22.7 million,
and fatal opioid overdoses costing $37.2 million, totalling to a
combined 60 million in losses. On a national scale, New York's opioid
crisis accounts for $19.3 million relating to healthcare costs and $7.5
million in lost productivity of the country's opioid crisis.*

Since 2017, the opioid crisis has been intensified by substances such as
fentanyl and xylazine being mixed with opioids. Some of thes e compounds
do not react to life-saving opioid antagonists like naloxone. To save
lives, and mitigate the crisis, it is necessary to start with knowing
what substances an individual may be coming in contact with.

This bill serves as the first step in combating this health and econom-
ical issue. To be able to cut back on these exorbitant costs made by the
opioid crisis, preliminary steps must be made first. This means decreas-
ing the amount of deaths occuring due to the influx of fentanyl and
xylazine by conducting drug checks. In addition, this bill will allow
individuals to test their drugs, without fear of retribution or criminal
justice outco mes, allowing them to make informed decisions about drug
use.

*Luo F, Li M, Florence C. State-Level Economic Costs of Opioid Use
Disorder and Fatal Opioid Overdose - United States, 2017. MMWR Mor b
Mortal Wkly Rep 2021;70:541-546. DOI:
http://dx.doi.org/10.15585/mmwr.mm7015a1

 
PRIOR LEGISLATIVE HISTORY:
2023-2024: S4880 / A7487

 
FISCAL IMPLICATIONS:  TBD

 
EFFECTIVE DATE:
This act shall take effect immediately; provided, however, that subdivi-
sions one, two, three and four of section 3309-c of the public health
law, as added by section one of this act, shall take effect on the first
of April next succeeding the fiscal year in which th is act shall have
become a law.  Effective immediately, the addition, amendment, and/or
repeal of any rule or regulation necessary for the implementation of
this act on its effective date are authorized to be made and completed
on or before such effective date.

2025-S56 - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                    56
 
                        2025-2026 Regular Sessions
 
                             I N  S E N A T E
 
                                (PREFILED)
 
                              January 8, 2025
                                ___________
 
 Introduced  by Sens. FERNANDEZ, CLEARE, JACKSON, MAY, RIVERA, SALAZAR --
   read twice and ordered printed, and when printed to  be  committed  to
   the Committee on Health
 
 AN  ACT  to  amend  the public health law, in relation to establishing a
   drug checking program including requirements for enhanced drug  check-
   ing service delivery and public health surveillance
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. The public health law is amended by adding  a  new  section
 3309-c to read as follows:
   § 3309-C. DRUG  CHECKING  SERVICES  PROGRAM. 1.   FOR PURPOSES OF THIS
 SECTION, THE FOLLOWING TERMS SHALL HAVE THE FOLLOWING MEANINGS:
   (A) "ENHANCED DRUG CHECKING SERVICES" MEANS  THE  UTILIZATION  OF  ALL
 FORMS  OF  DRUG TESTING EQUIPMENT INCLUDING COMPLEX TECHNOLOGY OR EQUIP-
 MENT DESIGNED TO ANALYZE SUBSTANCES AND  PROVIDE  RESULTS  AT  POINT  OF
 TESTING OR POINT OF CARE, WHICH MAY INCLUDE BUT IS NOT LIMITED TO, CHEM-
 ICAL  SCREENING DEVICES SUCH AS INFRARED SPECTROPHOTOMETERS, RAMAN SPEC-
 TROPHOTOMETERS, OR ION MOBILITY SPECTROMETERS.
   (B) "PUBLIC HEALTH SURVEILLANCE" MEANS THE CONTINUOUS  AND  SYSTEMATIC
 COLLECTION,  ANALYSIS,  AND  INTERPRETATION OF DATA NEEDED FOR THE PLAN-
 NING, IMPLEMENTATION,  AND  EVALUATION  OF  PUBLIC  HEALTH  INITIATIVES.
 PUBLIC HEALTH SURVEILLANCE MAY BE USED FOR THE FOLLOWING PURPOSES:
   (I)  AS  AN  EARLY WARNING SYSTEM FOR IMPENDING PUBLIC HEALTH EMERGEN-
 CIES;
   (II) TO DOCUMENT THE IMPACT OF AN INTERVENTION;
   (III) TO TRACK PROGRESS TOWARDS SPECIFIC GOALS;
   (IV) TO MONITOR AND CLARIFY THE EPIDEMIOLOGY OF HEALTH OUTCOMES; AND
   (V) TO INFORM THE PUBLIC HEALTH POLICY AND PRACTICES.
   2. THE DEPARTMENT SHALL:
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD00379-01-5

 S. 56                               2
 
   (A) ESTABLISH A PROGRAM TO PROVIDE, OR AUTHORIZE A LOCAL GOVERNMENT OR
 OTHER ENTITY TO PROVIDE ENHANCED DRUG CHECKING SERVICES TO ASSIST  INDI-
 VIDUALS  IN  DETERMINING WHETHER A DRUG OR CONTROLLED SUBSTANCE CONTAINS
 CONTAMINANTS, TOXIC SUBSTANCES, OR HAZARDOUS COMPOUNDS; AND
   (B)  ESTABLISH  PUBLIC  HEALTH  SURVEILLANCE  OF  THE UNREGULATED DRUG
 SUPPLY TO MONITOR TRENDS AND THE IMPACT ON HEALTH OUTCOMES AND  INCREASE
 PUBLIC AWARENESS OF NEW SUBSTANCES IN THE UNREGULATED DRUG SUPPLY.
   3.  ENHANCED DRUG CHECKING SERVICES PROGRAMS SHALL FOLLOW ALL POLICIES
 ESTABLISHED BY THE DEPARTMENT AND SUBMIT DATA IN ACCORDANCE  WITH  POLI-
 CIES ESTABLISHED BY THE DEPARTMENT.
   4. THE DEPARTMENT SHALL DEVELOP POLICIES AND PROCEDURES TO:
   (A) AUTHORIZE ENHANCED DRUG CHECKING SERVICE DELIVERY;
   (B)  UTILIZE  ENHANCED  DRUG  CHECKING  TECHNOLOGY  FOR  PUBLIC HEALTH
 SURVEILLANCE;
   (C) DEVELOP REQUIREMENTS FOR TECHNICIAN TRAINING  TO  ENSURE  ACCURATE
 POINT OF TESTING AND POINT OF CARE RESULTS;
   (D) IDENTIFY APPROPRIATE EQUIPMENT TO USE; AND
   (E) ESTABLISH REPORTING PROCESSES.
   5.  EMPLOYEES,  CONTRACTORS,  AND VOLUNTEERS OF THE DEPARTMENT, DIREC-
 TORS, MANAGERS, EMPLOYEES, CONTRACTORS, AND VOLUNTEERS OF  AN  ORGANIZA-
 TION  PROVIDING  DRUG CHECKING SERVICES, OWNERS OF PROPERTIES WHERE DRUG
 CHECKING SERVICES OCCUR, LOCAL GOVERNMENTS OR OTHER ENTITIES  AUTHORIZED
 BY  THE  DEPARTMENT,  AND INDIVIDUALS PRESENTING DRUGS OR SUBSTANCES FOR
 CHECKING, ACTING IN THE COURSE AND SCOPE OF  EMPLOYMENT  OR  ENGAGED  IN
 GOOD  FAITH  IN  THE  PROVISION  OF  ENHANCED DRUG CHECKING SERVICES, IN
 ACCORDANCE WITH ESTABLISHED PROTOCOLS, SHALL NOT BE SUBJECT TO:
   (A) ARREST, CHARGES, OR PROSECUTION PURSUANT TO THIS  ARTICLE  OR  ANY
 VIOLATION OR MISDEMEANOR, INCLUDING FOR ATTEMPTING, AIDING AND ABETTING,
 OR  CONSPIRACY  TO COMMIT A VIOLATION OR MISDEMEANOR PURSUANT TO ARTICLE
 TWO HUNDRED TWENTY OF THE PENAL LAW; OR
   (B) A CIVIL OR ADMINISTRATIVE PENALTY OR LIABILITY  OF  ANY  KIND,  OR
 DISCIPLINARY  ACTION  BY  A  PROFESSIONAL  LICENSING  BOARD, FOR CONDUCT
 RELATING TO THE PROVISION OF ENHANCED DRUG CHECKING SERVICES UNLESS SUCH
 CONDUCT WAS PERFORMED IN A NEGLIGENT MANNER OR IN BAD FAITH.
   6. THE DEPARTMENT AND LOCAL GOVERNMENTS OR ENTITIES AUTHORIZED BY  THE
 DEPARTMENT  SHALL  NOT  COLLECT, MAINTAIN, USE, OR DISCLOSE ANY PERSONAL
 INFORMATION RELATING TO AN INDIVIDUAL FROM WHOM  THE  DEPARTMENT,  LOCAL
 GOVERNMENT,  OR  ENTITY  RECEIVES  ANY DRUG OR SUBSTANCE FOR CHECKING OR
 DISPOSAL.
   7. THE RESULT OF ANY TEST CARRIED OUT BY THE DEPARTMENT OR AN  AUTHOR-
 IZED  LOCAL  GOVERNMENT  OR  ENTITY IN RELATION TO ANY DRUG OR SUBSTANCE
 PRESENTED FOR CHECKING SHALL NOT BE ADMISSIBLE AS EVIDENCE IN ANY CRIMI-
 NAL OR CIVIL PROCEEDINGS AGAINST THE INDIVIDUAL FROM WHOM  THE  DRUG  OR
 SUBSTANCE WAS RECEIVED, UNLESS SUBMITTED BY SUCH INDIVIDUAL.
   §  2. This act shall take effect on the first of April next succeeding
 the fiscal year in which this act shall have  become  a  law.  Effective
 immediately, the addition, amendment, and/or repeal of any rule or regu-
 lation  necessary  for  the  implementation of this act on its effective
 date are authorized to be made and completed on or before such effective
 date.

co-Sponsors

View additional co-sponsors

2025-S56A (ACTIVE) - Details

See Assembly Version of this Bill:: A808
Current Committee:: Senate Health
Law Section:: Public Health Law
Laws Affected:: Add §3309-c, Pub Health L

2025-S56A (ACTIVE) - Summary

2025-S56A (ACTIVE) - Sponsor Memo

                                 
BILL NUMBER: S56A

SPONSOR: FERNANDEZ
 
TITLE OF BILL:

An act to amend the public health law, in relation to establishing a
drug checking program including requirements for enhanced drug checking
service delivery and public health surveillance

 
PURPOSE OR GENERAL IDEA OF BILL:

To create a drug checking services program to assist individuals in
determining whether a drug or controlled substance contains contam-
inants, toxic substances, or hazardous compounds.

 
SUMMARY OF PROVISIONS:

Section 1 establishes the drug checking services program.

Section 2 sets the effective date.

JUSTIFICATION:

New York is in the middle of an overdose epidemic. For the past few
years, New York has exceeded national rates of opioid overdose deaths
with over 30 individuals per 100,000 dying from drug overdoses. The
amount of opioid deaths grew almost 300% between 2010 and 2020, effec-
tively responsible for 85% of all drug overdose deaths in New York in
2020.

In 2017 the CDC published a findings report of the state-level economic
costs of opioid use disorder and fatal opioid overdoses. It found opioid
use disorder has cost New York State an estimated $22.7 million, and
fatal opioid overdoses costing $37.2 million, totalling to a combined 60
million in losses. On a national scale, New York's opioid crisis
accounts for $19.3 million relating to healthcare costs and $7.5 million
in lost productivity of the country's opioid crisis.*

Since 2017, the opioid crisis has been intensified by substances such as
fentanyl and xylazine being mixed with opioids. Some of these compounds
do not react to life-saving opioid antagonists like naloxone. To save
lives, and mitigate the crisis, it is necessary to start with knowing
what substances an individual may be coming in contact with.

This bill serves as the first step in combating this health and econom-
ical issue. To be able to cut back on these exorbitant costs made by the
opioid crisis, preliminary steps must be made first. This means decreas-
ing the amount of deaths occuring due to the influx of fentanyl and
xylazine by conducting drug checks. In addition, this bill will allow
individuals to test their drugs, without fear of retribution or criminal
justice outcomes, allowing them to make informed decisions about drug
use.

*Luo F, Li M, Florence C. State-Level Economic Costs of Opioid Use
Disorder and Fatal Opioid Overdose - United States, 2017. MMWR Morb
Mortal Wkly Rep 2021;70:541-546. DOI:
http://dx.doi.org/10.15585/mmwr.mm7015a1

 
PRIOR LEGISLATIVE HISTORY:
2023-2024: 54880 / A7487

 
FISCAL IMPLICATIONS:

TBD

 
EFFECTIVE DATE:
This act shall take effect immediately; provided, however, that subdivi-
sions one, two, three and four of section 3309-c of the public health
law, as added by section one of this act, shall take effect on the first
of April next succeeding the fiscal year in which this act shall have
become a law. Effective immediately, the addition, amendment, and/or
repeal of any rule or regulation necessary for the implementation of
this act on its effective date are authorized to be made and completed
on or before such effective date.

2025-S56A (ACTIVE) - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   56--A
 
                        2025-2026 Regular Sessions
 
                             I N  S E N A T E
 
                                (PREFILED)
 
                              January 8, 2025
                                ___________
 
 Introduced  by Sens. FERNANDEZ, CLEARE, JACKSON, MAY, RIVERA, SALAZAR --
   read twice and ordered printed, and when printed to  be  committed  to
   the Committee on Health -- committee discharged, bill amended, ordered
   reprinted as amended and recommitted to said committee

 AN  ACT  to  amend  the public health law, in relation to establishing a
   drug checking program including requirements for enhanced drug  check-
   ing service delivery and public health surveillance
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. The public health law is amended by adding  a  new  section
 3309-c to read as follows:
   § 3309-C. DRUG  CHECKING  SERVICES  PROGRAM. 1.   FOR PURPOSES OF THIS
 SECTION, THE FOLLOWING TERMS SHALL HAVE THE FOLLOWING MEANINGS:
   (A) "ENHANCED DRUG CHECKING SERVICES" MEANS  THE  UTILIZATION  OF  ALL
 FORMS  OF  DRUG TESTING EQUIPMENT INCLUDING COMPLEX TECHNOLOGY OR EQUIP-
 MENT DESIGNED TO ANALYZE SUBSTANCES AND  PROVIDE  RESULTS  AT  POINT  OF
 TESTING OR POINT OF CARE, WHICH MAY INCLUDE BUT IS NOT LIMITED TO, CHEM-
 ICAL  SCREENING DEVICES SUCH AS INFRARED SPECTROPHOTOMETERS, RAMAN SPEC-
 TROPHOTOMETERS, OR ION MOBILITY SPECTROMETERS.
   (B) "PUBLIC HEALTH SURVEILLANCE" MEANS THE CONTINUOUS  AND  SYSTEMATIC
 COLLECTION,  ANALYSIS,  AND  INTERPRETATION OF DATA NEEDED FOR THE PLAN-
 NING, IMPLEMENTATION,  AND  EVALUATION  OF  PUBLIC  HEALTH  INITIATIVES.
 PUBLIC HEALTH SURVEILLANCE MAY BE USED FOR THE FOLLOWING PURPOSES:
   (I)  AS  AN  EARLY WARNING SYSTEM FOR IMPENDING PUBLIC HEALTH EMERGEN-
 CIES;
   (II) TO DOCUMENT THE IMPACT OF AN INTERVENTION;
   (III) TO TRACK PROGRESS TOWARDS SPECIFIC GOALS;
   (IV) TO MONITOR AND CLARIFY THE EPIDEMIOLOGY OF HEALTH OUTCOMES; AND
   (V) TO INFORM THE PUBLIC HEALTH POLICY AND PRACTICES.
   2. THE DEPARTMENT SHALL:
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.

                                                            LBD00379-03-5
 S. 56--A                            2
 
   (A) ESTABLISH A PROGRAM TO PROVIDE, OR AUTHORIZE A LOCAL GOVERNMENT OR
 OTHER ENTITY TO PROVIDE ENHANCED DRUG CHECKING SERVICES TO ASSIST  INDI-
 VIDUALS  IN  DETERMINING WHETHER A DRUG OR CONTROLLED SUBSTANCE CONTAINS
 CONTAMINANTS, TOXIC SUBSTANCES, OR HAZARDOUS COMPOUNDS; AND
   (B)  ESTABLISH  PUBLIC  HEALTH  SURVEILLANCE  OF  THE UNREGULATED DRUG
 SUPPLY TO MONITOR TRENDS AND THE IMPACT ON HEALTH OUTCOMES AND  INCREASE
 PUBLIC AWARENESS OF NEW SUBSTANCES IN THE UNREGULATED DRUG SUPPLY.
   3.  ENHANCED DRUG CHECKING SERVICES PROGRAMS SHALL FOLLOW ALL POLICIES
 ESTABLISHED BY THE DEPARTMENT AND SUBMIT DATA IN ACCORDANCE  WITH  POLI-
 CIES ESTABLISHED BY THE DEPARTMENT.
   4. THE DEPARTMENT SHALL DEVELOP POLICIES AND PROCEDURES TO:
   (A) AUTHORIZE ENHANCED DRUG CHECKING SERVICE DELIVERY;
   (B)  UTILIZE  ENHANCED  DRUG  CHECKING  TECHNOLOGY  FOR  PUBLIC HEALTH
 SURVEILLANCE;
   (C) DEVELOP REQUIREMENTS FOR TECHNICIAN TRAINING  TO  ENSURE  ACCURATE
 POINT OF TESTING AND POINT OF CARE RESULTS;
   (D) IDENTIFY APPROPRIATE EQUIPMENT TO USE; AND
   (E) ESTABLISH REPORTING PROCESSES.
   5.  EMPLOYEES,  CONTRACTORS,  AND VOLUNTEERS OF THE DEPARTMENT, DIREC-
 TORS, MANAGERS, EMPLOYEES, CONTRACTORS, AND VOLUNTEERS OF  AN  ORGANIZA-
 TION  PROVIDING  DRUG CHECKING SERVICES, OWNERS OF PROPERTIES WHERE DRUG
 CHECKING SERVICES OCCUR, LOCAL GOVERNMENTS OR OTHER ENTITIES  AUTHORIZED
 BY  THE  DEPARTMENT,  AND INDIVIDUALS PRESENTING DRUGS OR SUBSTANCES FOR
 CHECKING, ACTING IN THE COURSE AND SCOPE OF  EMPLOYMENT  OR  ENGAGED  IN
 GOOD  FAITH  IN  THE  PROVISION  OF  ENHANCED DRUG CHECKING SERVICES, IN
 ACCORDANCE WITH ESTABLISHED PROTOCOLS, SHALL NOT BE SUBJECT TO:
   (A) ARREST, CHARGES, OR PROSECUTION PURSUANT TO THIS  ARTICLE  OR  ANY
 VIOLATION OR MISDEMEANOR, INCLUDING FOR ATTEMPTING, AIDING AND ABETTING,
 OR  CONSPIRACY  TO COMMIT A VIOLATION OR MISDEMEANOR PURSUANT TO ARTICLE
 TWO HUNDRED TWENTY OF THE PENAL LAW; OR
   (B) A CIVIL OR ADMINISTRATIVE PENALTY OR LIABILITY  OF  ANY  KIND,  OR
 DISCIPLINARY  ACTION  BY  A  PROFESSIONAL  LICENSING  BOARD, FOR CONDUCT
 RELATING TO THE PROVISION OF ENHANCED DRUG CHECKING SERVICES UNLESS SUCH
 CONDUCT WAS PERFORMED IN A NEGLIGENT MANNER OR IN BAD FAITH.
   6. THE DEPARTMENT AND LOCAL GOVERNMENTS OR ENTITIES AUTHORIZED BY  THE
 DEPARTMENT  SHALL  NOT  COLLECT, MAINTAIN, USE, OR DISCLOSE ANY PERSONAL
 INFORMATION RELATING TO AN INDIVIDUAL FROM WHOM  THE  DEPARTMENT,  LOCAL
 GOVERNMENT,  OR  ENTITY  RECEIVES  ANY DRUG OR SUBSTANCE FOR CHECKING OR
 DISPOSAL.
   7. THE RESULT OF ANY TEST CARRIED OUT BY THE DEPARTMENT OR AN  AUTHOR-
 IZED  LOCAL  GOVERNMENT  OR  ENTITY IN RELATION TO ANY DRUG OR SUBSTANCE
 PRESENTED FOR CHECKING SHALL NOT BE ADMISSIBLE AS EVIDENCE IN ANY CRIMI-
 NAL OR CIVIL PROCEEDINGS AGAINST THE INDIVIDUAL FROM WHOM  THE  DRUG  OR
 SUBSTANCE WAS RECEIVED, UNLESS SUBMITTED BY SUCH INDIVIDUAL.
   §  2.  This act shall take effect immediately; provided, however, that
 subdivisions one, two, three and four of section 3309-c  of  the  public
 health  law,  as  added by section one of this act, shall take effect on
 the first of April next succeeding the fiscal year  in  which  this  act
 shall have become a law. Effective immediately, the addition, amendment,
 and/or repeal of any rule or regulation necessary for the implementation
 of  this  act  on  its  effective  date  are  authorized  to be made and
 completed on or before such effective date.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Senate Bill S56A

Sponsored By

Current Bill Status - In Senate Committee Health Committee

Bill Amendments

co-Sponsors

2025-S56 - Details

2025-S56 - Summary

2025-S56 - Sponsor Memo

2025-S56 - Bill Text download pdf

co-Sponsors

2025-S56A (ACTIVE) - Details

2025-S56A (ACTIVE) - Summary

2025-S56A (ACTIVE) - Sponsor Memo

2025-S56A (ACTIVE) - Bill Text download pdf

Comments

Senate Bill S56A

Share this bill

Sponsored By

Current Bill Status - In Senate Committee Health Committee

Bill Amendments

co-Sponsors

2025-S56 - Details

2025-S56 - Summary

2025-S56 - Sponsor Memo

2025-S56 - Bill Text download pdf

co-Sponsors

2025-S56A (ACTIVE) - Details

2025-S56A (ACTIVE) - Summary

2025-S56A (ACTIVE) - Sponsor Memo

2025-S56A (ACTIVE) - Bill Text download pdf

Comments